Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
~ FIELD
|
TM
FORCE
DE VICES
E XCE L LE N CE
DIAGNOSTICS |
PHARMA
Vol. 1 Issue 3
MEDICAL
SURGICALS
October 2011
www.medicinman.net
Editorial
EDITORS PICK
MR TO MD
INSIDE MEDICINMAN
HOW TO BE AN EFFECTIVE FRONT-LINE MANAGER HITENDRA KANSAL GETTING IT RIGHT WITH KEY ACCOUNTS RICHARD ILSLEY INDUSTRY THOUGHT LEADERS COMMENT ON KAM SHAHRUKH KHAN MANTRA DR. HEMANT MITTAL MUSIC, METRICS AND MANAGEMENT HANNO WOLFRAM 6
11
12
13
14
MR Strategy
One consequence of the shift to KAM in pharmaceutical sales and marketing has been to challenge received wisdom
MedicinMan
I ALWAYS AVOIDED PEOPLE WHO WERE NEGATIVE AND I WOULD SPEND A LOT OF TIME WITH PEOPLE WHO WANTED TO MAKE IT BIG IN LIFE.
that I travelled in an AC compartment of a train. When I joined work, I joined colleagues who were seniors by many years. I got a mixed bag Negative and Positive people. I always avoided people who would concentrate on negatives and I would spend a
Page 2
of the same. I would always challenge status quo in my job and would like to add newer dimensions. I felt proud that my work helped patients live longer and better. It is said that opportunity knocks only a few times in our lives. I also got a few
Manoj began his career as an MR with Serdia Pharma. He later moved to Novartis where he worked as an RBM and in the PMT. Currently he is Marketing Manager at an MNC, responsible for Global marketing support of Branded Generics Launches .
Hot on
DAVID EDGE: I would suggest that a key aspect to bear in mind here is that 1 st Line Managers manage Sales People. Whereas 2nd line Managers manage Sales Managers. So the key competencies you are developing with each role are different according to the 1st or 2nd line relationship you have. The 1st line Manager develops the Reps performance to be the best it can be. The 2nd line Manager develops the Managers to be the best people managers they can be. PRABHAKAR SHETTY The hierarchy works fairly well in MNCs where the roles are clearly defined. In desi companies, even the VP is assessed on the basis of the number Dr. Calls and Conversions (if the Owner is a little bit smarter). In many companies training is considered a waste of field working time. The trainer is told to go to the field and convert Doctors !! Visit Indian Pharma Connection (IPC) on Linkedin to view more discussions and connect with like-minded peers.
MedicinMan
*Indian Pharma Connection is a leading Pharma Linkedin Group. MedicinMan encourages its readers to actively participate in the online Pharma-sphere to learn and share valuable professional insights. Join MedicinMan on Linkedin here. Page 3
MedicinMan
Patient-Centric Approach in MR Sales Strategy
Well-educated medical representatives are valuable contributors to the broad body of knowledge that impacts healthcare decisions.1 The selling environment in healthcare has become increasingly complex in recent years. Today patients are taking a more proactive role with physicians in determining the best course of therapy. Reasons for this are: easy access to information on the Internet, looking for second opinion, becoming aware of the healthcare costs, mental blocks to various treatment methodologies, less awareness about disease consequences etc. It has been reported that 78% of the patients leave the doctors consultation room without understanding the treatment. Busy physicians are not always prepared to have an effective conversation with patients about managing a treatment. Doctors are comfortable with scientific aspects of drugs and treatment, but have difficulty translating the science into simple yet compelling communication for patients. This leads to poor patient compliance - such as cutting pills in half, skipping doses, failing to refill a prescription, postponing doctor visits, and relying on home remedies or OTC drugs. For example, a doctor is unable to convince a patient to stay on insulin therapy as the patient fears insulin dependence. The result is non-compliance with the prescribed regimen. Thus at present, dialogue between Medical Reps and physicians do not always translate into effective communication between physician and patients. A 2004 International Journal of Medical Marketing article states that compliance could get a significant boost if doctors explained more often and more thoroughly the prescribed medications, their value, how best to manage side effects, and the importance of compliance. Though patient education about the prescribed medication can be given most effectively by the doctor, it should also be supplemented and reinforced by the pharma companies. They need to expand their service to help physicians better engage patients in the appropriate therapeutic option. The traditional mode of communication of the pharmaceutical companies with their client physicians has been to provide them with the clinical and scientific aspects of their products. Now they should also prepare them to have an effective engagement with the patients. This can be done by developing tools which can help in making the patients understand the basics about
1CMR
2. TRAIN
3.
DEVELOP
4. EDUCATE PHYSICIANS ON PATIENT RELATIONSHIP WITH EASYTO UNDERSTAND COMMUNICATION THROUGH SEMINARS, WORKSHOPS AND OTHER TOOLS. 5..REGULAR NEWSLETTER FOR FIELD FORCE KNOWLEDGE AND MOTIENHANCEMENT AND MOTIVATION. VATION CEMENT.
the medications they are taking, the implications of the dosing schedule, common medication errors, common drug interactions, dos and donts of the prescription, understanding prescribing information etc. The message should be meaningful, compelling, and motivate patients to adhere to the prescribed regimen. MRs can be a key link between healthcare companies, medical professionals and patients. They can be a more valuable resource for physicians if they move the conversation beyond medical and clinical aspects. This can even be from latest news updates to giving tips to help them build their patient pool and practice. Knowledge driven MRs with patient-centric approach can become a trusted consultant to the physician and have positive impact on patient outcomes. Further, knowledgeable MRs will increase their value to the doctors allowing them to increase their number of calls and spend quality time with doctors. This Pull approach of ensuring that the patient takes the prescribed dosage and experiences better outcomes will lead to an increased uptake of medicines and sustainable higher sales growth.
REF: Patient compliance viewpoint adapted from a whitepaper by a USA based Marketing firm.
Medical RepDoctor interaction should address these 3 scarcities to be effective. Promedik Algorithms are based on current research and simplifies diagnosis and treatment.
Promedik Algorithms are very effective in engaging the doctors attention in the shortest possible time by conveying clinically relevant scientific research. Promedik Algorithms also
make the task of a Medical Rep easier and interesting by giving him a clear picture of the disease management sequence and where his product fits in. Promedik Algorithms enhance the MR-Dr. interaction and takes it from the level of mere product detailing to the delivery of actionable research based Rx information.
AM [S
To find out more call: Dr. Vishal Bansal : +91 97172 18558 Rahul Mishra : +91 96118 76767
E] PL
MedicinMan Creatives featured in:
MedicinMan
Hitendra Kansal
YOU CANT MANAGE PEOPLE BUT YOU MUST LEAD THEM; SO THAT EVEN IN YOUR ABSENCE, YOUR TEAM MEMBERS ACHIEVE WHAT THEY ARE EXPECTED TO.
Page 6
MedicinMan
Rs. 599/-
Rs. 799/-
starting at 10 copies and range from 30% to 45% off retail price based on quantity.
To place your orders or make an inquiry: anupsoans@medicinman.net +91 934 2232 949 +91 855 3030 949 To find out more about the programs email: anupsoans@medicinman.net
If you are willing to read HardKnocks for the GreenHorn, it means you are willing to do whatever it takes to build your career. - K. Hariram, Managing Director, Galderma
MedicinMan
Shiv Bhasin
THE PROUD MOMENT OF MY BECOMING AN AREA MANAGER CAME AFTER 7 YEARS. I BECAME THE YOUNGEST PERSON IN BURROUGHS WELLCOME AND THE CITY OF BHOPAL TO BECOME AN ASM.
good habit of reading business magazines and management books. By now, I had spent four years and the feeling of personal growth became very prominent. I started focusing on self development, giving feedback to marketing and participating meaningfully in company meetings. Luckily, a change in Area Manager and good relations with the Zone Manager helped me to get proper direction. The proud moment of my becoming an Area Manager came after 7 years. I became the youngest person in Burroughs Wellcome and the city of Bhopal to become an ASM. I moved to Baroda, Ahmedabad and Jaipur, learning and enjoying the job of a manager. I learnt that people skills are
Page 8
very important to build a strong team. The team observes you closely to see whether you can command, solve their problems and give them direction. In 1988, I was promoted as Overall-InCharge and given the charge of Gujarat state. After a good performance, the promotion as Zone Sales Manager came at Indore headquarters, my hometown, with M.P. and Maharashtra as my area. This position exposed to me to the nuances of managing a large geographic area and a big field team. One learns the art of problem-solving as a number of difficult situations are referred to you. The focus shifts to managing your Area Managers and coaching them to produce the desired performance.
MedicinMan
I started taking interest in Marketing and would provide feedback to the marketing team and often discuss strategies with them.
In 1999, I joined Duphar Interferan as their General Manager Sales. My assignment was to transform the company from general selling to a specialty driven company to promote the global products of Solvay. This was a challenging assignment wherein Solvay India was built up from very small beginnings to a respectable midsized company with its key brands occupying leadership positions in their therapeutic segments. In 2005, I was promoted as Vice President Domestic and Internation-
Shiv Bhasin
WHAT HAS CONSTANTLY DRIVEN ME ON THE PATH OF SUCCESS IS: STRONG AMBITION TO GROW ACHIEVEMENT ORIENTATION DEVELOPING AND UPGRADING MY SKILLS PEOPLE MANA G E M E N T SKILLS TO BUILD A TEAM COACHING SKILLS
Page 9
MedicinMan
www.eyeforpharma.com
The Pharma Key Account Management Report 20112012 is based on more than 50 interviews with KAM executives. These include 24 in-depth interviews with senior pharmaceutical executives and stakeholders as well as surveys of the pharma community involving 956 and 100 respondents respectively.
A KEY
ACCOUNT MAY BE LESS ABOUT IMMEDIATE SALES GAINS THAN BUILDING A MUTUALLY BENEFICIAL RELATIONSHIP IN WHICH A PACKAGE OF PRODUCTS AND SERVICES IS USED TO ACHIEVE LONG
METRICS NEEDED
There was general consensus among respondents that metrics are needed to support six key performance areas in KAM programs: valid direction of objectives and actions in account plans; quality of engagement with customers; sales progress; tactics that work; value delivered from a customer perspective; and results of mutual objectives. Ultimately, though, a companys ability to measure performance outcomes according to more complex KAM criteria will depend on having the right attitude and aims going in. It doesnt matter who or what you are, or what you have on your business card, comments James Bailey, UK regional business manager for Astellas. If you have a clear sense of purpose and clear reason for being there, which you communicate, you will get further. The Pharma KAM Report 2011-2012 identifies a
number of hurdles to measuring KAM value, both practical and technical. They start with instilling attitudinal change company-wide and from the top down. That can be particularly challenging where senior management have been brought up on a culture of calls per day. We are still of the belief that we need a nod and a handshake to get sales, until proved otherwise, comments Lars Werner, Leo Pharmas BU director, dermatology, Denmark and Sweden. As many as 71.4% of survey respondents said their companies continued to set, measure and report on call rates, while 28.6% measured call rates but generally used the data only when a sales issue arose.
FLEXIBLE TIMELINES
KAM measures also need to be flexible about timelines for program/product uptake or return on investment. This may be a function of different priorities in local health economies, how mature the product is, or brand objectives, such as wanting to get a compliance program properly bedded in before driving sales. The difficulty with KAM is not predicting the outcomefor example, setting the objectivethe difficulty is setting when, com-
-TERM HEALTH
OUTCOMES
Page 10
ments Lee Gittings, commercial effectiveness manager at Pfizer in the UK. KAM is a more nuanced approach to customers than traditional share-ofvoice platforms, with their emphasis on trumping the competition through sheer weight of numbers. A key account may be less about immediate sales gains than building a mutually beneficial relationship in which a package of products and services is used to achieve long-term health outcomes tailored to a local health economy or particular disease area. KAM measurements must therefore be able to capture performance across a wide range of parameters, consistent with the multiple strategic aims involved in selecting and targeting key customers. Among those highlighted in the report are long-term health outcomes; key milestones in account plans; value parameters, such as levels of patient education; patient-management objectives, such as drug adherence; customer, insight, engagement and satisfaction; and comparisons among accounts. For exclusive business insight into and analysis of KAM, download eyeforpharma's Pharma Key Account Management Report 2011-2012. Special Thanks to Jon Gwillim and Victoria Stinson of eyeforpharma
MedicinMan
A survey of senior managers from manufacturers, retailers and distributors in Europe and North America in 2009/10 considered their relationships with their major suppliers. Only around 15% of suppliers and their Key Account Managers seem to be getting it right. Yet around 65% of senior managers from those same or similar suppliers claim they are in the top 25% of best practice! Most suppliers equate Key Account Management with selling to big customers and a two-day training course. Most suppliers are getting it wrong. How are we getting it wrong? The most common errors observed are: Failure to identify the few critical success factors in other words what must we get right with this Key Account? Failure to define specifically what value means for the Key Account and therefore incurring cost without any return. Failure to measure the true profitability of the Key Account - and consequently taking poor decisions. Failure to adapt to the Key Account that requires a regional or global management approach.
Failure to engage senior managers from across the business in Key Account strategic planning by assuming that Key Account Management means selling to big customers. Failure to understand how the Key Account takes decisions, its strategic plans and needs, how it measures its suppliers and to engage at the highest level.
What does it all come down to? You have to recognise that getting it right with your Key Accounts is fundamental to the long term success of your company.
FOCUS FEATURE
The demands of effective key account management in the 21st Century are: 1. A clear simple key account strategy driven by the corporate strategy. 2. A clear competitive strategy that defines exactly where the growth is coming from and why; along with clarity about how value is added to the Key Account. 3. Serious attention from the most senior managers across all disciplines. 4. A multi-disciplinary team approach and not one Key Account Manager working in isolation. 5. Recognition that KAM means so much more than selling.
Richard Ilsley is Partner at Sales & Marketing Consulting Group (SMCG). E: richard.ilsley@smcg.net Page 11
MedicinMan
THOUGHT LEADERS
Our Editor, Anup Soans asked Linkedin Leaders to share their insights on KAM
I have worked extensively in the Pharma sector on KAM implementation for the last 10 years and there are some specific challenges in introducing KAM within this sector. Firstly to the positives, as Olivier has noted, the Pharma industry really do understand influencers and complex sales environments. Also, it is an industry that invests signifSandra Du Cross icantly in training and seeks to take a lead. By and large the account managers are very well educated, often with science degrees, and so have no problems grasping the ideas and thinking. Olivier Riviere In today's economy the concept of KAM can/must be modernized and extended to situations where a vendor decides to engage in a proactive way with carefully selected targets. Sticking to the classic definition might be adequate for some companies or sectors where resources can and should be focused on a few opportunities at hand. However, using this more aggressive definition of KAM can help many companies define and execute very valid growth strategies. This of course requires a very realistic and controlled approach but I believe that the future belongs to companies able to use this modernized approach.
E: olivier.riviere @atoem-consulting.com
The real challenge is that the ideas and thinking of KAM do not fit very neatly into this sector. KAM exists around the assumption that Seller selects Buyers with whom they have a common/shared strategic goal. The Seller will then apply the appropriate resources to servicing that account such that both parties benefit. This model is easy to understand in the world of FMCG where the 2 parties maybe Wal-Mart and Proctor and Gamble. We saw in a recently posted example from Richard Ilsley how these companies had worked together to their mutual benefit. In the Pharma sector however, it can be a real challenge to find a common strategic goal - put crudely, Pharma companies want to make a profit from the often excellent products they have developed and the purchasers of healthcare want to reduce costs. This fundamental difference in overall goal leads to a lack of openness and trust and as such any replication of the FMCG model is difficult if not impossible. Does this mean Pharma companies should not employ KAM? Well no, not at all, but what they must do is be realistic with what can be achieved. There are some excellent KAM tools which can be selected for the world of Pharma - but selection is the key. We need to take what works well and adds value and disregard what adds complication and no value. There has been a great deal of time, money and energy expended on tryE: sandra@handsassociates.com ing to bang a square peg into a round hole! KAM is business of patience. It requires more time to understand system, know key people, develop confidence with key people. KAM is unconventional selling. Unfortunately not enough guidance is provided to these people and in absence of results as expected within time frame fatigue Nitin Nigam settles in fast. This business require a very mature management.
I've seen companies use KAM as a title vs. a process. The KAMer is the one who should lead the team in the KAM framework, but the process and roles during each stage of the buying cycle needs to be well defined. Additionally, the process needs to be flexible enough to allow the person who has the greatest credibility and relationship with the client to lead the selling effort. This is not saying they lead the team, but lead the conDavid Kirsch tact and relationship with the client. If you have someone who has the ability to develop a trusted advisor relationship with the client, take advantage of it regardless of their role in your company. E: djk1216@comcast.net Page 12
MedicinMan
I was recently asked by a company to conduct a "Motivational" talk for some of their fresher Employees.
Like in most such cases, the HR (human resource) department was very clear with their requirements. I still remember the HR guy calling me a few days before and saying, "Well Doc, we pride in being one of the very few Multinational companies that like to employ freshers. While the market standard requires 1-2yrs of experience, we believe in harnessing and cultivating talent from the beginning. As you will understand, we require them to be completely motivated to face the challenges ahead and build a long term relationship with us". To simplify what he meant - "We hire freshers because they come cheap. We want them to work as much as we demand them to.
IT IS KNOWN
THAT SHAHRUKH KHAN HAS MADE IT TO THE TOP THE HARD WAY SLEEPING ON A BENCH FOR A WEEK AND BORROWING RS. 20 FROM A FRIEND TO TRAVEL TO FILM CITY
Dr. Hemant is a well-known Behavioral, Emotional and Sexual Health Consultant. He is the Owner of Mind Mantra Wellness Concepts and a Leading Blogger at:
www.themindpath.blogspot.com
E: eksoch@gmail.com Page 13
MedicinMan
Not only in music is the harmony of triads an important element of style, it is important in improving our
well-being and good feelings as well. We find such triads in management studies and in our daily lives. One of these triads is related to figures that are regularly used to measure results or dedication. William Hewlett once said: You only can manage what you measure, and what you measure gets done! Many of the KPIs used in our companies follow this sentence, at least the first half of it. An absolute prerequisite for measuring and therefore management, are numbers. If many of them are collected in a table or spreadsheet, Microsoft has told us that these are called data. To alter data into infor-
mation, data need to be displayed graphically. For the mostly optical people it appears to be easy to extract or make them understand a specific and clear informational message derived from these data. A companys product strategy can easily be displayed and supported with such information. Acknowledging that the details of a growth strategy vary significantly from others, the creation of information from data can well be a challenge. Questions like: Does this information mirror our strategic objectives? or Will this information point to the right strategic direction? should be a mandatory part if you want to achieve and support a coherent and consistent strategy. The third tone of the triad becoming ever more important reflects the question How can I create knowledge out of this
information for me or my company? They say we are living in the era of knowledge today. But where is the knowledge of my company? Does it make sense if knowledge is stored in the heads of a few or should it be made available for many? How can knowledge being in the heads of a few be made accessible to others in the same organization? At the end the question is left how we handle our individual knowledge or how we can transfer all this information into knowledge accessible by all concerned. The n e c e s sa r y preconditions, some call that IT-systems, are available, allowing us to intone the valuable and value adding triad of transforming data into information and at the end create accessible knowledge. Pitifully this triad only can rarely be enjoyed.
Lots of Data
Information
Knowled ge
Action !
QUESTIONS LIKE DOES THIS INFORMATION MIRROR OUR STRATEGIC OBJECTIVES? OR WILL THIS INFORMATION POINT TO THE RIGHT STRATEGIC DIRECTION? SHOULD BE A MANDATORY PART IF YOU WANT TO ACHIEVE AND SUPPORT A COHERENT AND CONSISTENT STRATEGY.
Page 14
Question: Being a medical representative, which of the 5 territories below would you chose to work in and why? Hanno Wolfram is Managing Director at Innov8 GmbH and Co-Founder at Pharmainstitut with over 30 years of experience in the German and International Health Markets. Contact him at : hanno@innov8.de
MedicinMan
ANNOUNCING
ACADEMY
www.medicinman.net
EXECUTIVE TEAM
EDITOR Anup Soans EXECUTIVE EDITOR Joshua Soans COO Arvind Nair ADVISORY BOARD Prof. Vivek Hattangadi Jolly Mathews EDITORIAL BOARD Shashin Bodawala Salil Kallianpur Dr. Shalini Ratan Prabhakar Shetty
ADVISORS
To receive the latest WHAT THE PHARMA CEO WANTS FROM THE BRAND MANAGER issue of MedicinMan A New Book by Prof. Vivek Hattangadi every month in your Brand management gurus say the role of the CEO is tied inexmailbox, visit tricably to the brand. They further opine that the most powerful www.medicinman.net person in the organization i.e. the CEO should be the brand custodian. However this is easier said than done. Therefore, in this and enter your email milieu, the brand manager in the Indian pharmaceutical market ID in the Subscribe to (IPM) has a key role to play. Although the brand managers have MedicinMan widget been given various nomenclatures Product Manager, Therapy Manager, Product Sales Manager and a few years below the latest back they were also called as Sales Promotion Manager, the issue. most appropriate one is Brand Manager.
Send your queries, comments and feedback to: E:
anupsoans@medicinman.net
M:
+91 934 2232 949
E:
arvindnair@medicinman.net
M:
+91 987 020 1422
What exactly is the role of a brand manager? How does he build a brand? What are the characteristics of an effective brand manager in the pharma industry? And most importantly, what does the custodian of the brand - the CEO - want from the brand manager? How can the brand manager fulfill the CEOs Send enquiries to: expectations? What are his worries? vivekhattangadi@yahoo.co.in 'WHAT THE PHARMA CEO WANTS FROM THE BRAND MANAGER' answers all your questions on this important topic. Although the book is intended for those who have been recently initiated into pharma brand management, many pharma industry leaders recommend this book even for the practicing brand managers who desire to revisit the basics. "What the Pharma CEO Wants from the Brand Manager is a must read for new entrants in product management and even useful for all those who wish to revisit the basics of pharmaceutical marketing. Chapters/Sections on self analysis, forecasting and brand plan are good. These can make every brand manager introspect/revisit on his current work." Satish Dandekar, Sr. Vice President, Ipca Laboratories Ltd.
Published and Printed for MedicinMan by Joshua Soans at 22 North Road, Cooke Town, Bangalore84